Ncf1/NOX2 stimulators (Redoxis/Karolinska)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNcf1/NOX2 stimulators (Redoxis/Karolinska)
Drug Alias Namesmall molecules (Redoxis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH Oxidase 2 stimulants
TargetsNADPH Oxidase 2
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRedoxis AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A